The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Stocks in Asia were tepid in Tuesday morning trade, while investors looked toward to a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to...Asia Marketsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
While earnings usually come in substantially ahead of expectations — as much as 4 or 5 percentage points is not unusual — the downward direction in the outlook doesn't speak...Earningsread more
U.S. President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of...Politicsread more
"We missed being the dominant mobile operating system by a very tiny amount. We were distracted during our antitrust trial. We didn't assign the best people to do the work,"...Technologyread more
PatientsLikeMe was bought by UnitedHealth following a review by Trump's Treasury Department, which scrutinized the start-up because it's backed by Chinese cash.Technologyread more
Some traders think the energy rally is about to wane, despite the sector being one of June's big winners.ETF Edgeread more
At least one major investor, hedge fund manager John Paulson, believes the agricultural giant Monsanto and Syngenta, the Swiss pesticide company it offered to buy in May, continue to be in deal talks and aren't far apart on price, according to someone who has been briefed on the matter.
Paulson, who reportedly took a small stake in Syngenta in recent months, would likely use that position to support a Monsanto purchase if the economics were attractive, this source said. Paulson met recently with the Swiss company's management and thinks they could be receptive to an improved deal, added this person.
The existence of Paulson's Syngenta stake and his likely support for the deal were first reported by Bloomberg News.
Indeed, a survey of almost 100 fund managers conducted recently by Bernstein Research suggested that a number of Syngenta shareholders support the deal in principle—but would like to see a price premium of at least 5 percent above the $45 billion Monsanto has already offered.
Sara Miller, a spokeswoman for Monsanto, declined to comment on the Paulson involvement, but said the company believes there is broad-based support for the strategic rationale behind a deal. "We look forward to advancing these conversations," she added.
A spokesman for Syngenta could not immediately be reached.